Kazuko Matsuda - 12 Feb 2025 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Role
Chief Medical Officer, Director
Signature
/s/ Yuichi Iwaki, attorney-in-fact
Issuer symbol
MNOV
Transactions as of
12 Feb 2025
Transactions value $
$0
Form type
4
Filing time
14 Feb 2025, 16:52:26 UTC
Previous filing
10 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNOV Employee Stock Option (Right to Buy) Award $0 +100,000 $0 100,000 12 Feb 2025 Common Stock 100,000 $1.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a period of one year in equal monthly installments from the 2/12/2025 date of grant.